Kamada (KMDA) Equity Average (2018 - 2026)
Kamada (KMDA) reported Equity Average of $264.2 million for Q1 2026, up 3.33% on a YoY basis from $255.7 million in Q1 2025, and down 1.09% quarter-over-quarter from $267.2 million in Q4 2025.
Kamada (KMDA) Equity Average (2018 - 2026) Analysis & Trends
Kamada has reported Equity Average for 9 years, with the latest figure at $264.2 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average rose 3.33% year-over-year to $264.2 million; the trailing twelve-month figure through Mar 2026 stood at $264.2 million (up 3.33% YoY), and the FY2025 full-year result was $264.3 million, up 4.98% from the prior year.
- Equity Average for Q1 2026 stood at $264.2 million, down from $267.2 million in the prior quarter.
- The five-year high for Equity Average was $267.2 million in Q4 2025, with the low at $85.9 million in Q3 2022.
- Historically, Equity Average has averaged $203.5 million across 5 years, with a median of $245.3 million in 2024.
- Annual changes were most pronounced in 2022 — Equity Average plunged 52.81% — and 2024, when it jumped 181.28%.
- Kamada's Equity Average stood at $88.1 million in 2022, then jumped by 173.8% to $241.2 million in 2023, then rose by 6.7% to $257.4 million in 2024, then rose by 3.8% to $267.2 million in 2025, then slipped by 1.09% to $264.2 million in 2026.
- The last three Equity Average figures came in at $264.2 million (Q1 2026), $267.2 million (Q4 2025), and $262.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.15 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 493.55 Mn |
| 10 | Kamada | 505.05 | -73.15 Mn | 19.12 Mn | 264.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 264.23 Mn |
| Dec 31, 2025 | 267.15 Mn |
| Sep 30, 2025 | 262.59 Mn |
| Jun 30, 2025 | 255.96 Mn |
| Mar 31, 2025 | 255.71 Mn |
| Dec 31, 2024 | 257.37 Mn |
| Sep 30, 2024 | 253.21 Mn |
| Jun 30, 2024 | 248.83 Mn |
| Mar 31, 2024 | 245.27 Mn |
| Dec 31, 2023 | 241.21 Mn |
| Sep 30, 2023 | 207.57 Mn |
| Jun 30, 2023 | 88.46 Mn |
| Mar 31, 2023 | 88.10 Mn |
| Dec 31, 2022 | 88.10 Mn |
| Sep 30, 2022 | 85.87 Mn |
| Jun 30, 2022 | 173.36 Mn |
| Mar 31, 2022 | 175.99 Mn |
| Dec 31, 2021 | 179.22 Mn |
| Sep 30, 2021 | 181.98 Mn |
| Jun 30, 2021 | 181.78 Mn |